Immune Dysfunction in Chronic Lymphocytic Leukemia: The Role for Immunotherapy

E-ISSN： 1873-4286|18|23|3389-3398

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.23, 2012-08, pp. : 3389-3398

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pentostatin in chronic lymphocytic leukemia

By Sauter Craig Lamanna Nicole Weiss Mark A

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1217-1222

Informa Healthcare

Access to resources Recommend Favorite

The role of high-dose corticosteroids in the treatment of chronic lymphocytic leukemia

By Smolej Lukáš

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 7, 2012-07 ,pp. : 1009-1017

Informa Healthcare

Access to resources Recommend Favorite

Evolving role of monoclonal antibodies in the treatment of chronic lymphocytic leukemia

By Kharfan-Dabaja Mohamed A Fahed Rabih Hussein Mohamad Santos Edgardo S

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 11, 2007-11 ,pp. : 1799-1815

Informa Healthcare

Access to resources Recommend Favorite

Bendamustine for treatment of chronic lymphocytic leukemia

By Chang Julie Elizabeth Kahl Brad Steven

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1495-1505

Informa Healthcare

Access to resources Recommend Favorite

Lenalidomide in lymphomas and chronic lymphocytic leukemia

By Wiernik Peter H

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 4, 2013-03 ,pp. : 475-488

Informa Healthcare

Access to resources Recommend Favorite